Michael Buckley has over 25 years of experience in biotech developing monoclonal antibodies and antibody drug conjugates for oncology and immunology indications. He has held leadership roles at multiple biotech companies, directing preclinical and clinical development programs. Currently, he works as an independent consultant focusing on preclinical development and manufacturing of biologics from Phase I through commercial stage.